-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK, Relation Therapeutics Collaborate on Human Cellular Data Project

MT Newswires·07/30/2026 04:13:11
Listen to the news
04:13 AM EDT, 07/30/2026 (MT Newswires) -- British drugmaker GSK (GSK.L) and Relation Therapeutics entered into a strategic research partnership aimed at generating large-scale human cellular perturbation data to support the discovery of potential new therapeutic targets. Relation Therapeutics will use advanced human cellular disease models and experimental systems to produce the perturbation datasets, which will capture how human cells respond to genetic and pharmacological interventions, according to a Thursday release. The biotech is entitled to up to $110 million in upfront and milestone payments under the agreement.